Results 281 to 290 of about 352,925 (341)

Morphine modulates doxorubicin uptake and improves efficacy of chemotherapy in an intracranial xenograft model of human glioblastoma.

, 2016
Martina Da Ros, Anna Lisa Iorio, D. Consolante, Francesco Cardile, Monica Muratori, Ornella Fantappiè, M Lucchesi, Milena Guidi, Claudio Pisano, Iacopo Sardi   +9 more
openalex   +1 more source

Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy [PDF]

Circulation Research, 2020
Kendall B Wallace, Paulo J Oliveira
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Doxorubicin Nanoconjugates

Journal of Nanoscience and Nanotechnology, 2014
Doxorubicin is one of the most widely administered drugs for treatment of cancer. The shortcomings commonly encountered with this drug are severe cardiotoxicity, narrow therapeutic indices, and the development of multiple drug resistance. Hence, several nanoparticulate drug delivery systems have been designed to overcome these limitations and to ...
Kannan, Deepa, Siddhartha, Singha, Tapobrata, Panda   +2 more
openaire   +2 more sources

Liposomal Doxorubicin

Journal of Drug Targeting, 1996
Doxorubicin is a potent antineoplastic agent with activity against numerous human cancers. Encapsulation of doxorubicin inside a liposome alters bioavailability, biodistribution and thus its biological activity significantly. The physical properties of the liposome (size, lipid components and lipid dose) play a major role in determining drug retention ...
P G, Tardi, N L, Boman, P R, Cullis
openaire   +2 more sources

Doxorubicin (z.B. Doxorubicin „Ebewe“, Adriblastin®)

2006
aufgrund zahlreicher Berichte uber Nekrosen erfolgt die Einstufung von Doxorubicin als ...
openaire   +1 more source

Doxorubicin/doxorubicin-liposomal/ifosfamide

Reactions Weekly, 2022
openaire   +1 more source

Doxorubicin cardiotoxicity

Cancer Treatment Reviews, 1982
D V, Unverferth, R D, Magorien, C V, Leier, S P, Balcerzak   +3 more
openaire   +2 more sources